ELMOD2
protein-codingELMO domain containing 2, the group of ELMO domain containing
Gene summary
This gene encodes one of six engulfment and motility (ELMO) domain-containing proteins. This gene is thought to play a role in antiviral responses. Mutations in this gene may be involved in the cause of familial idiopathic pulmonary fibrosis. [provided by RefSeq, Sep 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~29.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0800504
Submitter: ClinGen
The *ELMOD2* gene was first reported in relation to an unknown inheritance disorder of familial idiopathic pulmonary fibrosis in 2006 (Hodgson et al., PMID: 16773575). There has not been further evidence in the literature associating this gene with a specific phenotype. There is no proband described in this paper. Currently, there are no OMIM phenotypes associated with this gene. A gene-disease relationship in the published case report was postulated by genome wide linkage analysis combined with haplotype association. However, the families were reportedly all from within three rural municipalities where the prevalence of FPF was 50-fold higher than in the rest of the country and potentially shared a common ancestor. This evidence was not scored in the present curation due to no variant being discussed. In summary, there is no evidence for a causal role for *ELMOD2* in an unknown inheritance disorder of familial idiopathic pulmonary fibrosis has been reported. This classification was approved by the ClinGen ILD GCEP on the meeting date October 27, 2025 (SOP Version 11).
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ELMOD2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_153702.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 4 | 5 | |||
| missense | 38 | 4 | 42 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 0 | 0 | 43 | 8 | 0 | 51 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_714913.1 | 8 | MANE Select | |
| Ensembl | ENSP00000326342.3 | 8 | MANE Select | |
| Ensembl | ENSP00000422582.1 | 5 | Standard | |
| Ensembl | ENSP00000427265.1 | 1 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- miR-targeted genes in lymphocytes - TarBase
- miR-targeted genes in muscle cell - TarBase
- Lung fibrosis
Biological Process
- positive regulation of GTPase activity
- regulation of defense response to virus
- defense response to virus
Molecular Function
- GTPase activator activity
Cellular Component
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000323570
- Coding exons
- 8
- Length
- 29613
- Individuals with no LoFs
- 125713
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 31
- Defined
- 125744
- p
- 0.000123
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.565 | 129 | 148 | 0.870 | 0.00000693 | 1969 |
| Missense (PolyPhen) | 46 | 60.742 | 0.75731 | 829 | ||
| Synonymous | 0.249 | 46 | 48.2 | 0.954 | 0.00000231 | 471 |
| Loss of Function | 3.10 | 4 | 18.3 | 0.218 | 0.00000102 | 221 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00019 | 0.00018 | rare |
| European (Non-Finnish) | 0.00021 | 0.00020 | rare |
| South Asian | 0.000076 | 0.000065 | rare |
| Other | 0.00020 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Acts as a GTPase-activating protein (GAP) toward guanine nucleotide exchange factors like ARL2, ARL3, ARF1 and ARF6, but not for GTPases outside the Arf family. Regulates IFN-related antiviral responses. {ECO:0000269|PubMed:17452337, ECO:0000269|PubMed:19966137}.;
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- LoFtool
- 0.470
- RVIS EVS
- 0.19
- RVIS percentile EVS
- 66.82
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.876
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |